These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 18391587)

  • 1. Gene therapy for acute renal failure.
    Torras J; Cruzado JM; Herrero-Fresneda I; Grinyo JM
    Contrib Nephrol; 2008; 159():96-108. PubMed ID: 18391587
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acute renal failure: growth factors, cell therapy, and gene therapy.
    Humes HD; MacKay SM; Funke AJ; Buffington DA
    Proc Assoc Am Physicians; 1997 Nov; 109(6):547-57. PubMed ID: 9394416
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vivo transfection of NF-kappaB decoy oligodeoxynucleotides attenuate renal ischemia/reperfusion injury in rats.
    Cao CC; Ding XQ; Ou ZL; Liu CF; Li P; Wang L; Zhu CF
    Kidney Int; 2004 Mar; 65(3):834-45. PubMed ID: 14871403
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gene expression in early ischemic renal injury: clues towards pathogenesis, biomarker discovery, and novel therapeutics.
    Devarajan P; Mishra J; Supavekin S; Patterson LT; Steven Potter S
    Mol Genet Metab; 2003 Dec; 80(4):365-76. PubMed ID: 14654349
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Poly(ADP-ribose) polymerase-mediated cell injury in acute renal failure.
    Devalaraja-Narashimha K; Singaravelu K; Padanilam BJ
    Pharmacol Res; 2005 Jul; 52(1):44-59. PubMed ID: 15911333
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intravenous cell therapy for acute renal failure with serum amyloid A protein-reprogrammed cells.
    Kelly KJ; Kluve-Beckerman B; Zhang J; Dominguez JH
    Am J Physiol Renal Physiol; 2010 Aug; 299(2):F453-64. PubMed ID: 20534870
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gene therapy in cardiovascular disease. Current status.
    Francis SC; Katovich MJ; Gelband CH; Raizada MK
    Am J Pharmacogenomics; 2001; 1(1):55-66. PubMed ID: 12173315
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cell Therapy Using Human Induced Pluripotent Stem Cell-Derived Renal Progenitors Ameliorates Acute Kidney Injury in Mice.
    Toyohara T; Mae S; Sueta S; Inoue T; Yamagishi Y; Kawamoto T; Kasahara T; Hoshina A; Toyoda T; Tanaka H; Araoka T; Sato-Otsubo A; Takahashi K; Sato Y; Yamaji N; Ogawa S; Yamanaka S; Osafune K
    Stem Cells Transl Med; 2015 Sep; 4(9):980-92. PubMed ID: 26198166
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fetal Kidney Cells Can Ameliorate Ischemic Acute Renal Failure in Rats through Their Anti-Inflammatory, Anti-Apoptotic and Anti-Oxidative Effects.
    Gupta AK; Jadhav SH; Tripathy NK; Nityanand S
    PLoS One; 2015; 10(6):e0131057. PubMed ID: 26086475
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bioartificial kidney for full renal replacement therapy.
    Humes HD
    Semin Nephrol; 2000 Jan; 20(1):71-82. PubMed ID: 10651220
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular therapy for renal diseases.
    Lipkowitz MS; Klotman ME; Bruggeman LA; Nicklin P; Hanss B; Rappaport J; Klotman PE
    Am J Kidney Dis; 1996 Oct; 28(4):475-92. PubMed ID: 8840936
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acute renal failure after whole body ischemia is characterized by inflammation and T cell-mediated injury.
    Burne-Taney MJ; Kofler J; Yokota N; Weisfeldt M; Traystman RJ; Rabb H
    Am J Physiol Renal Physiol; 2003 Jul; 285(1):F87-94. PubMed ID: 12657560
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Leukocytes, cell adhesion molecules and ischemic acute renal failure.
    Rabb H; O'Meara YM; Maderna P; Coleman P; Brady HR
    Kidney Int; 1997 May; 51(5):1463-8. PubMed ID: 9150459
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gene-modified Mesenchymal Stem Cell-based Therapy in Renal Ischemia- Reperfusion Injury.
    Xu H; Chen C; Hu L; Hou J
    Curr Gene Ther; 2017; 17(6):453-460. PubMed ID: 29446737
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acute renal failure. II. Experimental models of acute renal failure: imperfect but indispensable.
    Lieberthal W; Nigam SK
    Am J Physiol Renal Physiol; 2000 Jan; 278(1):F1-F12. PubMed ID: 10644651
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prospects of antisense oligodeoxynucleotides to alleviate renal ischaemia-reperfusion injury.
    Matsuyama M; Yoshimura R
    Expert Opin Biol Ther; 2004 Dec; 4(12):1931-7. PubMed ID: 15571455
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Par-4 is a novel mediator of renal tubule cell death in models of ischemia-reperfusion injury.
    Xie J; Guo Q
    Am J Physiol Renal Physiol; 2007 Jan; 292(1):F107-15. PubMed ID: 16896190
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cellular and molecular neurosurgery: pathways from concept to reality--part I: target disorders and concept approaches to gene therapy of the central nervous system.
    Zlokovic BV; Apuzzo ML
    Neurosurgery; 1997 Apr; 40(4):789-803; discussion 803-4. PubMed ID: 9092853
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antibodies to both ICAM-1 and LFA-1 do not protect the kidney against toxic (HgCl2) injury.
    Ghielli M; Verstrepen WA; De Greef KE; Helbert MH; Ysebaert DK; Nouwen EJ; De Broe ME
    Kidney Int; 2000 Sep; 58(3):1121-34. PubMed ID: 10972676
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Administered mesenchymal stem cells enhance recovery from ischemia/reperfusion-induced acute renal failure in rats.
    Lange C; Tögel F; Ittrich H; Clayton F; Nolte-Ernsting C; Zander AR; Westenfelder C
    Kidney Int; 2005 Oct; 68(4):1613-7. PubMed ID: 16164638
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.